ExCell Bio Group
PrivateLast Round
Series B
Extension
May 10, 2023
Est. Valuation
$1.19B
Total Funding Raised
$193.27M
Company Overview
ExCell Bio Group operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B Extension round in May 2023.
ExCell Bio Group is a biotechnology company that supplies biological reagents, cell culture media, serum products, and assay kits to customers in the biopharmaceutical, cell and gene therapy, and stem cell research sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExCell Bio Group Comparables
Compare ExCell Bio Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jianshun Biosciences Co., Ltd. | 89% | |
| Shanghai BasalMedia Technologies Co., Ltd. | 89% | |
| Duoning Biotechnology | 88% |
For institutional investors. Book with your work email.
ExCell Bio Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 10, 2023 | ||||
| Series B Extension | Jan 8, 2023 | ||||
| Growth Equity | Dec 9, 2021 | ||||
| Series B | Oct 26, 2021 | ||||
| Series B Extension | Aug 26, 2021 | ||||
Series B | Jun 17, 2021 |
For institutional investors. Book with your work email.
ExCell Bio Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agricultural Bank of China International | Series B Extension |
| HM Capital | Series B Extension |
| Legend Capital | Series B |
| Yonghua Capital | Series A, Series A Extension |
| CICC Capital | Series B |
| MPC | Series B |
| 金浦产业投资基金管理有限公司 | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 10, 2023
$14.3M round with Agricultural Bank of China International and Jinpu Investment.
- Dec 9, 2021
$40M round completed with 3 investors.
For institutional investors. Book with your work email.
ExCell Bio Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ExCell Bio Group's valuation, stock price, and market status.
Is ExCell Bio Group a public or private company?
ExCell Bio Group is a private company.
What is the current stock price of ExCell Bio Group?
ExCell Bio Group is a private company, so its shares have no public market price. Caplight tracks ExCell Bio Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExCell Bio Group worth (valuation)?
ExCell Bio Group's valuation is estimated at $1.2B based on funding round data.
Can I buy ExCell Bio Group stock?
ExCell Bio Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExCell Bio Group's last funding round?
ExCell Bio Group's most recent funding round was Series B Extension on May 10, 2023.
Who are the main investors in ExCell Bio Group?
Key investors in ExCell Bio Group include Legend Capital, Yonghua Capital, MPC, CPE.
Will ExCell Bio Group IPO soon?
No public IPO plans have been announced for ExCell Bio Group.
How can I track ExCell Bio Group secondary market activity?
Caplight tracks bids, offers, and trades in ExCell Bio Group's shares on secondary markets.